Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Preventive Maintenance of Analytical Instruments – V 2.0

Posted on By

BA-BE Studies: SOP for Preventive Maintenance of Analytical Instruments – V 2.0

Standard Operating Procedure for Preventive Maintenance of Analytical Instruments in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/184/2025
Supersedes SOP/BA-BE/184/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for the planning, execution, documentation, and verification of preventive maintenance (PM) activities for analytical instruments used in BA/BE bioanalytical studies, ensuring optimal performance and regulatory compliance.

2. Scope

This SOP applies to all analytical instruments used in the bioanalytical laboratory, including LC-MS/MS systems, HPLC units, analytical balances, centrifuges, vortex mixers, and

nitrogen evaporators used in BA/BE study analysis.

3. Responsibilities

  • Instrument User: Ensures PM due dates are tracked, reports issues, and participates during service activities.
  • Engineering/Maintenance Staff: Performs or coordinates preventive maintenance as per schedule and logs activities.
  • QA Representative: Verifies that PM is completed within schedule and reviews documentation for completeness.
See also  BA-BE Studies: SOP for Room Temperature Monitoring in Sample Collection Areas - V 2.0

4. Accountability

The Bioanalytical Department Head is accountable for ensuring timely preventive maintenance of all analytical instruments to avoid breakdowns and ensure uninterrupted compliance-driven operations.

5. Procedure

5.1 Maintenance Schedule Preparation

  1. Prepare and maintain a Preventive Maintenance Calendar for all instruments in Annexure-1: PM Schedule Tracker.
  2. Schedule PM frequency based on:
    • Manufacturer recommendations
    • Instrument usage frequency
    • Criticality to study operations
  3. Ensure vendor service contracts are in place for third-party PM where applicable.

5.2 Execution of Preventive Maintenance

  1. Perform PM activities on the scheduled date or within ±3 working days.
  2. Use equipment-specific maintenance SOPs or vendor checklists for the activity.
  3. Ensure the system is in shutdown mode and tagged “Under Maintenance.”
  4. Document all tasks in Annexure-2: Preventive Maintenance Log:
    • Instrument ID
    • Date and Time
    • Activity performed (e.g., vacuum pump oil change, filter replacement, calibration)
    • Observations and completion status

5.3 Post-Maintenance Qualification

  1. After completion, run system suitability test (SST) or calibration check as applicable.
  2. Record SST results in instrument logbook and attach to maintenance record.
  3. If SST fails, do not release the instrument until repeat PM or troubleshooting is completed.
See also  BA-BE Studies: SOP for Logging Receipt of Samples from Clinical Site - V 2.0

5.4 Delayed or Missed Maintenance

  1. If PM is delayed beyond scheduled window:
    • Immediately notify QA
    • Document reason in Annexure-3: Deviation Report for PM
    • Do not use the instrument until PM is completed and qualified

5.5 Labeling and Status Update

  1. Affix “PM Completed” sticker with:
    • Date of maintenance
    • Next due date
    • Performed by
  2. Update PM tracker accordingly.

5.6 Review and Verification

  1. QA shall review PM records monthly and ensure no due dates are missed.
  2. Audit trail, calibration verification, and checklist completeness will be verified.
  3. Corrective action shall be initiated for recurring delays.

6. Abbreviations

  • PM: Preventive Maintenance
  • LC-MS/MS: Liquid Chromatography–Mass Spectrometry
  • SST: System Suitability Test
  • QA: Quality Assurance

7. Documents

  1. PM Schedule Tracker – Annexure-1
  2. Preventive Maintenance Log – Annexure-2
  3. Deviation Report for PM – Annexure-3

See also  BA-BE Studies: SOP for Medical History Documentation in Healthy Volunteers - V 2.0

8. References

  • ICH Q10: Pharmaceutical Quality System
  • 21 CFR Part 211 – Equipment Maintenance
  • Instrument-Specific Maintenance SOPs

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: PM Schedule Tracker

Instrument ID Instrument Name PM Due Date PM Done Date Status
LCMS-002 Triple Quad MS 10/04/2025 09/04/2025 Completed

Annexure-2: Preventive Maintenance Log

Date Instrument ID Activity Performed Performed By Remarks
09/04/2025 LCMS-002 Replaced vacuum oil, cleaned ESI source Sunita Reddy Stable baseline achieved

Annexure-3: Deviation Report for PM

Instrument ID Scheduled PM Date Actual Date Reason for Delay Impact on Study Corrective Action
HPLC-011 05/04/2025 12/04/2025 Service engineer unavailable Instrument not used during delay Alternate vendor assigned

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
17/04/2025 2.0 Updated PM tracker, deviation handling, and annexures Audit Readiness QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Equipment Sterilization and Assembly Validation – V 2.0
Next Post: Analytical Method Development: Solvent Selection for NMR – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version